Innovative Eyewear Inc. (LUCY)
LUCY trades on Nasdaq in Health Care, Ophthalmic Goods. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1808377/000182912626002695/0001829126-26-002695-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | LUCY on Nasdaq |
| Sector | Health Care |
| Industry | Ophthalmic Goods |
| Country | United States |
| IPO year | 2022 |
| SEC CIK | 0001808377 |
| SEC industry code | Ophthalmic Goods |
| Incorporated in | FL |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $2.7M |
| Net income | -$7.6M |
| Operating income | Not in SEC XBRL data |
| Net margin | -285.2% |
| Operating margin | Operating income not reported |
| Revenue growth | +62.6% |
| Cash | $6.5M |
| Total assets | $10.1M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 2.6× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-09 |
| Cash and burn | $3.2M cash; operating cash flow -$1.8M a quarter. | Report 2026-09-30 |
| Shares outstanding | 8,712,263 (2026-11-09); 5,350,183 a year earlier; 12,917,239 three years earlier. 3y figure adjusted for split (1-for-20 overall). | Cover page 2026-11-09 |
| Reverse splits, 3 years | 1; latest 1-for-20 on 2024-07-18 | Source 2024-07-18 |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | 1 (8-K item 3.01) | 8-K 2026-10-15 |
| Auditor | Cherry Bekaert LLP, Chicago, Illinois, United States | PCAOB Form AP 2026-03-26 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $1.6M, sold $76K on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $1.0M | -$2.3M | -$1.5M | $3.2M | No debt tags | $3.8M | 10-Q 2026-11-09 |
| Q2 2026 2026-06-30 | $1.0M | -$1.7M | -$1.9M | $2.5M | No debt tags | $3.4M | 10-Q 2026-08-14 |
| Q1 2026 2026-03-31 | $774K | -$2.3M | -$2.5M | $4.4M | No debt tags | $3.0M | 10-Q 2026-05-14 |
| Q4 2025 2025-12-31 | $960K | -$1.9M | -$1.4M | $6.5M | No debt tags | $2.7M | 10-K 2026-03-25 |
| Q3 2025 2025-09-30 | $668K | -$1.8M | -$1.5M | $6.7M | No debt tags | $2.4M | 10-Q 2026-11-09 |
| Q2 2025 2025-06-30 | $579K | -$2.1M | -$2.1M | $7.6M | No debt tags | $2.0M | 10-Q 2026-08-14 |
| Q1 2025 2025-03-31 | $455K | -$1.8M | -$2.3M | $5.3M | No debt tags | $1.7M | 10-Q 2026-05-14 |
| Q4 2024 2024-12-31 | $691K | -$2.1M | -$1.9M | $2.6M | No debt tags | $1.6M | 10-K 2026-03-25 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-1 | 2026-07-23 |
| Latest annual report | 10-K | 2026-03-25 |
| Latest quarterly / interim | 10-Q | 2026-11-09 |
| Latest current report | 8-K | 2026-10-15 |
| Latest proxy | DEF 14A | 2026-10-05 |
Source: SEC EDGAR submissions feed, 266 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -2.1% |
| 1 month | -5.2% |
| 3 months | +7.2% |
| Year to date | -19.0% |
| 1 year | -47.9% |
| From 52-week high | -53.6% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Other listings for this company
| Ticker | Name | Price |
|---|---|---|
| LUCYW | Innovative Eyewear Inc. Series A Warrants 8/16/27 | $0.0281 |
Peers in Ophthalmic Goods
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| RXST | RxSight Inc. | $5.30 | -0.38% | $222.2M |
| STAA | STAAR Surgical Company | $26.01 | -1.44% | $1.3B |
| EYE | National Vision Holdings Inc. | $18.74 | +2.43% | $1.5B |
| WRBY | Warby Parker Inc. | $26.23 | -4.41% | $3.3B |
| BLCO | Bausch + Lomb Corporation Common Shares | $20.88 | -1.00% | $7.5B |
| COO | The Cooper Companies Inc. | $61.88 | -1.23% | $11.8B |
| ALC | Alcon Inc. | $73.64 | -0.65% | $36.8B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier